data_2jnq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jnq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 mtm . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 106.354 -1.721 . . . . 72.430000000000007 106.354 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.33 173.65 11.39 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.234 0.54 . . . . 73.120000000000005 110.749 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.9 m -81.23 -63.05 1.48 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.352 1.061 . . . . 71.409999999999997 108.509 170.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.0 -150.41 1.82 Allowed Glycine 0 C--N 1.341 0.841 0 N-CA-C 109.697 -1.361 . . . . 65.239999999999995 109.697 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 60.96 -174.21 0.13 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.634 1.174 . . . . 72.310000000000002 110.375 -166.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 58.44 84.52 0.1 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.104 1.762 . . . . 73.109999999999999 111.352 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.08 -169.04 39.37 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.462 1.506 . . . . 73.329999999999998 112.863 -176.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -177.41 170.84 2.05 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 128.124 2.57 . . . . 60.229999999999997 107.662 165.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mp -110.4 156.82 20.27 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.772 2.029 . . . . 63.530000000000001 110.297 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.14 158.95 27.3 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 121.056 0.455 . . . . 62.229999999999997 110.433 172.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.414 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 26.6 t80 -53.28 -36.95 61.72 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.784 1.634 . . . . 75.319999999999993 113.971 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -111.49 33.75 4.53 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.171 1.788 . . . . 62.229999999999997 111.029 -170.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.33 124.17 70.36 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 107.523 -1.288 . . . . 42.439999999999998 107.523 162.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -61.19 156.81 43.11 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.474 2.116 . . . . 75.150000000000006 113.34 164.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.0 pt -126.66 -4.96 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.717 1.607 . . . . 75.430000000000007 113.61 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.439 ' CE2' ' HA ' ' A' ' 169' ' ' GLU . 11.2 m-85 47.6 76.89 0.1 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.653 1.581 . . . . 75.239999999999995 113.143 170.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.68 160.08 0.96 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.815 -0.629 . . . . 72.519999999999996 110.07 169.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.45 0.24 0.32 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.749 1.22 . . . . 73.340000000000003 112.209 167.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -118.16 -16.74 9.71 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.857 2.063 . . . . 54.210000000000001 111.514 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.2 38.26 7.35 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 123.788 0.708 . . . . 32.210000000000001 112.483 169.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.16 -16.39 64.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.721 1.378 . . . . 72.540000000000006 114.721 -167.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.268 31.2 mm 35.74 66.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 128.733 2.813 . . . . 62.43 110.489 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.38 151.89 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 127.93 2.492 . . . . 73.530000000000001 108.611 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -65.04 127.01 29.83 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 128.196 2.598 . . . . 75.25 107.775 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -51.11 -41.44 23.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 123.305 0.642 . . . . 74.409999999999997 111.431 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.414 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -68.49 -41.42 84.78 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-O 118.986 -0.897 . . . . 72.109999999999999 111.154 -175.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.64 -41.01 93.11 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.669 1.234 . . . . 72.209999999999994 110.679 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -57.34 -57.12 14.03 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.96 0.904 . . . . 72.120000000000005 108.89 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.2 t -56.14 -50.97 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 109.129 -0.693 . . . . 74.219999999999999 109.129 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.3 -32.47 73.89 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 119.463 1.028 . . . . 72.230000000000004 112.032 -167.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.483 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 4.5 tttt -48.22 -47.05 35.89 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.418 1.008 . . . . 74.319999999999993 108.828 173.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.483 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 24.7 m-85 -68.69 -43.67 75.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.482 -0.933 . . . . 75.549999999999997 108.482 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -64.0 -21.98 66.73 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.157 -0.965 . . . . 71.319999999999993 112.102 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -93.93 -20.05 20.37 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 125.33 1.452 . . . . 74.430000000000007 112.483 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -94.42 -52.55 4.28 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 120.346 1.43 . . . . 74.420000000000002 107.722 173.148 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.406 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.2 m-30 -90.24 43.1 1.13 Allowed 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.822 2.049 . . . . 72.310000000000002 108.245 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -54.25 -42.27 69.74 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 125.932 1.693 . . . . 73.239999999999995 109.136 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -65.1 -27.9 69.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.78 0.832 . . . . 73.420000000000002 111.878 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.9 -5.13 58.22 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.979 1.712 . . . . 71.230000000000004 112.301 -176.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.44 95.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 120.818 1.644 . . . . 63.409999999999997 109.0 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -80.94 142.9 33.03 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.003 -1.48 . . . . 72.430000000000007 107.003 168.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 mmtm -107.41 150.25 26.97 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.509 -1.293 . . . . 74.230000000000004 107.509 164.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.37 170.54 16.45 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.836 0.855 . . . . 74.239999999999995 108.77 171.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.15 -42.68 99.0 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.586 0.754 . . . . 54.509999999999998 110.152 168.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.86 2.63 2.46 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.888 1.275 . . . . 75.519999999999996 112.505 173.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.55 46.4 55.29 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 125.915 1.721 . . . . 45.43 111.352 169.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.407 ' HB3' ' H ' ' A' ' 48' ' ' GLY . 1.1 t80 -86.54 -100.21 0.07 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.216 -0.661 . . . . 74.439999999999998 109.216 -175.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 47' ' ' PHE . . . 138.38 112.42 1.08 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.325 1.917 . . . . 71.109999999999999 108.682 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -137.04 159.24 42.49 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.202 1.801 . . . . 74.219999999999999 108.447 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.5 mt -142.39 142.24 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 106.694 -1.595 . . . . 74.140000000000001 106.694 170.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.79 133.46 43.25 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.985 0.914 . . . . 73.129999999999995 108.716 165.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -129.9 12.19 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.779 -0.646 . . . . 71.540000000000006 110.611 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.61 -22.3 16.93 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 119.217 0.917 . . . . 52.109999999999999 112.176 170.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -73.91 -25.49 60.03 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.847 1.259 . . . . 51.109999999999999 112.456 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.25 -23.05 64.74 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.432 1.014 . . . . 73.219999999999999 110.58 167.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 m120 61.57 -6.35 0.12 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.975 1.472 . . . . 72.430000000000007 114.975 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.6 mt -45.81 143.86 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 128.337 2.655 . . . . 64.540000000000006 111.006 -172.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -102.91 134.78 45.76 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.311 0.96 . . . . 75.430000000000007 112.088 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.4 tt -104.3 148.39 9.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 125.842 1.657 . . . . 73.510000000000005 107.582 172.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -70.05 112.88 6.74 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.427 -1.694 . . . . 71.120000000000005 106.427 165.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 t -107.47 -166.47 1.15 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.153 -1.425 . . . . 71.120000000000005 107.153 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -150.93 159.62 44.44 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.717 -1.586 . . . . 74.420000000000002 106.717 167.003 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -113.88 116.71 29.73 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.01 1.324 . . . . 74.430000000000007 110.463 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 1.7 ttpm? -57.33 -26.73 61.4 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.814 1.646 . . . . 73.310000000000002 113.16 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.31 -22.22 64.69 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.645 1.578 . . . . 71.140000000000001 112.422 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.4 m -149.04 10.4 0.79 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.177 0.991 . . . . 64.219999999999999 112.451 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.5 mt 54.27 49.42 18.62 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.879 1.323 . . . . 74.319999999999993 109.519 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.7 pt -108.44 151.72 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 124.933 1.293 . . . . 73.219999999999999 108.618 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.99 124.09 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.048 -1.834 . . . . 64.129999999999995 106.048 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -143.09 179.54 6.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.83 1.652 . . . . 65.530000000000001 107.767 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.94 168.83 19.14 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.962 0.905 . . . . 73.409999999999997 110.652 169.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.56 175.73 13.52 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.711 -1.218 . . . . 75.230000000000004 107.711 140.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -105.25 136.77 44.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.708 1.203 . . . . 74.530000000000001 108.745 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.9 mt -67.9 157.34 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.748 -1.204 . . . . 71.420000000000002 107.748 170.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.4 mt -117.96 -43.7 2.75 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.271 0.629 . . . . 74.430000000000007 110.839 -175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -138.17 165.01 27.72 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.743 -1.223 . . . . 74.420000000000002 109.316 169.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.58 168.16 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 124.776 1.23 . . . . 60.439999999999998 108.894 173.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -135.72 155.59 50.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.733 1.213 . . . . 74.310000000000002 109.165 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -139.03 144.64 38.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.551 -1.278 . . . . 75.530000000000001 107.551 167.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -141.0 169.03 18.38 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.211 1.405 . . . . 75.310000000000002 107.73 169.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -103.94 147.45 27.34 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.248 -1.019 . . . . 71.25 108.248 170.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -145.92 149.34 34.04 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 125.817 1.647 . . . . 72.420000000000002 107.352 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -144.68 131.91 20.63 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.309 -1.738 . . . . 75.140000000000001 106.309 159.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.77 -169.57 40.8 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.375 -1.09 . . . . 61.340000000000003 110.375 -175.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.94 123.74 42.06 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.025 -0.732 . . . . 74.349999999999994 109.025 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.6 mt -102.35 149.13 24.65 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.566 -0.901 . . . . 73.120000000000005 108.566 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.5 mm -79.47 138.87 19.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 126.192 1.797 . . . . 71.430000000000007 107.005 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -122.91 43.66 2.87 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.716 0.806 . . . . 72.120000000000005 112.511 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.8 mt -46.27 114.78 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 C-N-CA 126.917 2.087 . . . . 75.120000000000005 106.753 -175.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.2 m -90.63 169.22 11.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.741 -1.577 . . . . 74.319999999999993 106.741 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.8 p -133.96 171.9 13.55 Favored 'General case' 0 C--O 1.238 0.5 0 O-C-N 121.174 -0.954 . . . . 73.120000000000005 108.908 157.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.407 ' C ' ' H ' ' A' ' 94' ' ' ARG . 6.7 ttpt -53.73 -38.49 64.38 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.293 -0.88 . . . . 73.230000000000004 111.978 -174.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.42 HD21 ' CG ' ' A' ' 138' ' ' ASP . 41.0 m-80 -72.34 20.11 0.07 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.468 2.307 . . . . 75.109999999999999 112.466 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 92' ' ' LYS . 22.5 mmt180 49.11 27.14 1.64 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 128.091 2.556 . . . . 73.310000000000002 113.065 -174.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.88 159.86 24.58 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 120.862 -1.149 . . . . 73.519999999999996 108.424 163.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -170.32 167.06 8.56 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.995 1.718 . . . . 74.140000000000001 107.901 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.569 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.4 pt -146.75 174.59 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 127.088 2.155 . . . . 74.439999999999998 107.914 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -141.72 84.07 1.88 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.835 -0.802 . . . . 74.319999999999993 108.835 -171.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.09 174.41 10.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.983 0.913 . . . . 64.450000000000003 112.533 -168.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.77 169.01 8.58 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.065 2.146 . . . . 53.130000000000003 111.68 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -83.97 -33.29 24.64 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.306 -0.628 . . . . 73.219999999999999 109.306 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -91.69 39.37 1.01 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.769 0.828 . . . . 51.530000000000001 110.851 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -91.79 123.0 64.54 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 117.166 -1.397 . . . . 74.109999999999999 110.106 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -65.78 124.13 12.3 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.182 2.588 . . . . 74.439999999999998 110.405 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.22 173.69 8.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 125.735 1.614 . . . . 74.409999999999997 108.334 173.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -113.7 149.66 34.41 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 123.037 0.535 . . . . 73.120000000000005 110.808 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.11 164.38 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 124.96 1.304 . . . . 75.409999999999997 109.689 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 p -79.93 131.83 35.92 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 122.089 0.947 . . . . 64.239999999999995 108.462 168.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -109.2 78.13 1.11 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.777 -1.564 . . . . 71.340000000000003 106.777 153.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m 61.28 15.13 6.18 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.562 1.545 . . . . 71.349999999999994 113.288 166.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.35 -24.36 3.23 Favored Glycine 0 CA--C 1.521 0.416 0 O-C-N 120.808 -1.182 . . . . 75.140000000000001 111.752 -173.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -90.1 143.28 26.92 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.533 -1.284 . . . . 55.240000000000002 107.533 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.18 126.64 38.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.737 -1.949 . . . . 75.239999999999995 105.737 166.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 tp -126.01 159.21 33.32 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.629 -0.878 . . . . 75.329999999999998 108.629 173.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -119.81 119.54 33.89 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.145 1.778 . . . . 74.239999999999995 109.255 -171.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.55 179.64 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.344 1.057 . . . . 74.329999999999998 110.76 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -81.65 139.57 34.9 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.583 1.953 . . . . 73.450000000000003 110.69 173.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.21 -41.11 36.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.402 1.481 . . . . 75.340000000000003 113.241 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -63.45 -19.85 65.07 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.963 1.256 . . . . 74.439999999999998 113.515 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.5 mmt -84.56 -22.83 29.95 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.697 0.799 . . . . 52.219999999999999 111.163 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.05 63.66 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 128.398 2.679 . . . . 73.430000000000007 111.603 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.35 -170.68 2.7 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.984 -1.073 . . . . 71.109999999999999 111.73 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.9 p -58.96 -1.44 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 127.046 2.139 . . . . 75.319999999999993 113.598 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.35 9.21 22.45 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 117.42 -1.767 . . . . 55.210000000000001 111.762 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.23 147.64 44.02 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.849 2.325 . . . . 72.25 109.018 172.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -94.81 105.02 16.93 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.236 -1.394 . . . . 75.219999999999999 107.236 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.5 tt -78.4 118.16 25.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 124.634 1.173 . . . . 71.239999999999995 109.277 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -59.43 140.25 56.34 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.505 -0.747 . . . . 74.239999999999995 109.078 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.24 158.02 76.2 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.868 1.267 . . . . 75.420000000000002 111.095 174.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.55 161.36 42.39 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.63 2.22 . . . . 63.240000000000002 110.277 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.2 -145.6 0.33 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.32 -1.363 . . . . 74.120000000000005 107.32 166.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.472 ' ND2' ' H ' ' A' ' 133' ' ' ASN . 1.5 p-10 -59.94 -82.04 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 125.44 1.496 . . . . 65.340000000000003 109.083 -175.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.472 ' H ' ' ND2' ' A' ' 132' ' ' ASN . 6.4 m120 -102.04 0.47 35.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.855 1.662 . . . . 64.150000000000006 110.306 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.9 p -138.12 -172.93 3.38 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.434 1.494 . . . . 73.230000000000004 110.857 -150.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 tp -126.02 143.22 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 106.18 -1.785 . . . . 74.439999999999998 106.18 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.78 177.56 7.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.648 1.113 . . . . 75.310000000000002 108.017 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.3 mt -114.08 145.71 41.24 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.917 1.287 . . . . 73.239999999999995 107.965 170.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.42 ' CG ' HD21 ' A' ' 93' ' ' ASN . 32.4 t0 -142.15 153.98 44.5 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.878 2.071 . . . . 53.130000000000003 109.906 170.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.94 142.04 27.83 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 118.427 -0.797 . . . . 73.430000000000007 110.017 -164.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.6 t -77.33 -5.57 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 114.544 1.313 . . . . 71.430000000000007 114.544 -163.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.514 HG13 ' H ' ' A' ' 142' ' ' LYS . 3.4 pt 29.34 -88.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 127.674 2.39 . . . . 74.420000000000002 116.155 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.514 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.8 OUTLIER -86.03 128.56 34.88 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.922 2.089 . . . . 75.549999999999997 109.574 -175.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.97 99.03 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 125.017 1.327 . . . . 73.349999999999994 111.097 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.453 ' CD ' ' HZ2' ' A' ' 142' ' ' LYS . 11.6 pt-20 -152.57 -169.43 3.34 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.203 2.601 . . . . 73.140000000000001 110.12 -177.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -133.9 179.58 6.15 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.025 1.73 . . . . 74.349999999999994 110.105 -172.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.6 163.78 22.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 126.913 2.085 . . . . 71.120000000000005 106.478 159.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.0 137.0 37.45 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.903 -1.888 . . . . 75.409999999999997 105.903 161.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -147.37 142.94 27.61 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.819 0.736 . . . . 74.420000000000002 110.075 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -146.79 24.32 1.2 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 118.839 0.745 . . . . 74.230000000000004 112.635 -157.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -109.89 -111.65 3.39 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 110.366 -1.094 . . . . 75.25 110.366 -155.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -134.15 164.82 26.51 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.614 -1.624 . . . . 75.219999999999999 106.614 157.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 20.6 pt -127.08 160.51 35.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 127.141 2.176 . . . . 73.409999999999997 109.111 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -142.91 151.55 41.12 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.546 1.138 . . . . 73.409999999999997 109.706 -168.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -149.27 -178.78 6.59 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.793 -1.188 . . . . 63.340000000000003 107.793 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 77.4 mt -128.26 175.77 8.2 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 123.952 1.834 . . . . 73.310000000000002 110.973 -167.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 24.2 m -128.43 92.09 3.37 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.406 -2.442 . . . . 73.129999999999995 104.406 159.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 24.6 t -109.68 80.17 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 101.617 -3.475 . . . . 65.209999999999994 101.617 166.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -76.43 -15.39 59.93 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 122.326 1.06 . . . . 71.530000000000001 111.246 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -72.48 -44.49 62.23 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.824 1.65 . . . . 64.209999999999994 109.909 -153.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 4.3 t30 -125.05 5.0 7.93 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.168 0.587 . . . . 72.219999999999999 111.89 167.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.428 ' CD2' ' HA ' ' A' ' 176' ' ' SER . 34.8 m170 52.23 36.67 20.01 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 119.003 0.82 . . . . 72.209999999999994 111.933 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.423 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 3.0 p -147.37 142.45 27.1 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 120.422 -1.424 . . . . 74.230000000000004 107.613 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -142.91 170.19 16.16 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.54 1.064 . . . . 74.239999999999995 110.288 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.1 mm -98.25 137.98 24.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 106.999 -1.482 . . . . 74.109999999999999 106.999 160.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -159.71 161.31 34.78 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.299 1.04 . . . . 75.230000000000004 108.572 161.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 134.64 -168.17 23.65 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 118.581 0.628 . . . . 73.450000000000003 111.757 175.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -102.4 169.52 8.63 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.398 1.599 . . . . 75.120000000000005 110.348 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 68.33 -85.13 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 128.05 2.54 . . . . 53.039999999999999 113.281 -173.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.439 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -122.68 -23.49 5.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.391 1.077 . . . . 74.310000000000002 112.106 169.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.69 177.14 23.95 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 125.643 1.592 . . . . 73.319999999999993 111.468 167.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.569 ' CE1' HG23 ' A' ' 97' ' ' ILE . 51.2 m-85 -117.8 140.0 50.3 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 126.353 1.861 . . . . 72.120000000000005 108.071 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.46 99.27 10.0 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 129.626 3.171 . . . . 53.119999999999997 107.53 170.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.96 179.07 3.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 123.092 0.557 . . . . 74.310000000000002 110.298 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.7 t -64.34 148.89 49.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.273 -1.01 . . . . 61.310000000000002 108.273 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.78 166.73 13.33 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.026 -1.472 . . . . 60.439999999999998 107.026 158.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.428 ' HA ' ' CD2' ' A' ' 161' ' ' HIS . 92.0 p -149.25 -149.68 0.31 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 119.76 -0.776 . . . . 73.450000000000003 111.152 171.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.5 p -149.39 -106.32 0.07 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.786 2.034 . . . . 74.319999999999993 107.06 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -88.74 112.05 3.88 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 108.118 -1.993 . . . . 71.420000000000002 108.118 165.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . 0.312 0.1 OUTLIER 68.23 -172.03 0.19 Allowed 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.158 1.383 . . . . 73.25 112.06 159.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 53.0 tp -67.64 81.65 0.18 Allowed 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.755 -1.216 . . . . 72.109999999999999 109.339 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 50.01 56.31 8.1 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.925 2.49 . . . . 71.340000000000003 115.893 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -80.31 -48.76 12.52 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.841 1.423 . . . . 74.109999999999999 114.841 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 61.9 m170 31.73 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 128.742 2.817 . . . . 74.530000000000001 114.216 -163.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -104.3 90.41 3.55 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.481 0.712 . . . . 71.430000000000007 109.949 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.77 -128.22 0.22 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.515 1.126 . . . . 62.420000000000002 110.053 169.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 17.0 p80 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 125.155 1.382 . . . . 74.540000000000006 109.996 -179.938 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 mtm . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 106.354 -1.721 . . . . 72.43 106.354 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.33 173.65 11.39 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.234 0.54 . . . . 73.12 110.749 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.9 m -81.23 -63.05 1.48 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.352 1.061 . . . . 71.33 108.509 170.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.0 -150.41 1.82 Allowed Glycine 0 C--N 1.341 0.841 0 N-CA-C 109.697 -1.361 . . . . 65.24 109.697 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 60.96 -174.21 0.13 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.634 1.174 . . . . 72.31 110.375 -166.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 58.44 84.52 0.1 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.104 1.762 . . . . 65.32 111.352 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.08 -169.04 39.37 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.462 1.506 . . . . 73.33 112.863 -176.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.439 ' HB3' HD12 ' A' ' 152' ' ' ILE . . . -177.41 170.84 2.05 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 128.124 2.57 . . . . 60.23 107.662 165.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mp -110.4 156.82 20.27 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.772 2.029 . . . . 60.42 110.297 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.14 158.95 27.3 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 121.056 0.455 . . . . 62.23 110.433 172.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.421 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 26.6 t80 -53.28 -36.95 61.72 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.784 1.634 . . . . 72.41 113.971 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -111.49 33.75 4.53 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.171 1.788 . . . . 62.23 111.029 -170.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.33 124.17 70.36 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 107.523 -1.288 . . . . 40.53 107.523 162.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -61.19 156.81 43.11 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.474 2.116 . . . . 60.43 113.34 164.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.0 pt -126.66 -4.96 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.717 1.607 . . . . 75.43 113.61 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.471 ' CE2' ' HA ' ' A' ' 169' ' ' GLU . 11.2 m-85 47.6 76.89 0.1 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.653 1.581 . . . . 74.21 113.143 170.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.68 160.08 0.96 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.815 -0.629 . . . . 63.13 110.07 169.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.45 0.24 0.32 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.749 1.22 . . . . 73.34 112.209 167.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -118.16 -16.74 9.71 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.857 2.063 . . . . 51.02 111.514 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.2 38.26 7.35 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 123.788 0.708 . . . . 25.43 112.483 169.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.16 -16.39 64.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.721 1.378 . . . . 72.54 114.721 -167.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.268 31.2 mm 35.74 66.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 128.733 2.813 . . . . 62.43 110.489 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.38 151.89 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 127.93 2.492 . . . . 63.42 108.611 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -65.04 127.01 29.83 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 128.196 2.598 . . . . 61.42 107.775 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -51.11 -41.44 23.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 123.305 0.642 . . . . 74.35 111.431 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.421 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -68.49 -41.42 84.78 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-O 118.986 -0.897 . . . . 72.11 111.154 -175.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.64 -41.01 93.11 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.669 1.234 . . . . 72.21 110.679 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -57.34 -57.12 14.03 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.96 0.904 . . . . 71.45 108.89 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.452 HG13 HG21 ' A' ' 77' ' ' VAL . 53.2 t -56.14 -50.97 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 109.129 -0.693 . . . . 71.23 109.129 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.3 -32.47 73.89 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 119.463 1.028 . . . . 72.23 112.032 -167.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.483 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 4.5 tttt -48.22 -47.05 35.89 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.418 1.008 . . . . 65.42 108.828 173.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.483 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 24.7 m-85 -68.69 -43.67 75.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.482 -0.933 . . . . 75.55 108.482 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.428 ' CD1' HD12 ' A' ' 50' ' ' ILE . 5.6 m-85 -64.0 -21.98 66.73 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.157 -0.965 . . . . 71.32 112.102 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -93.93 -20.05 20.37 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 125.33 1.452 . . . . 72.14 112.483 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.417 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -94.42 -52.55 4.28 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 120.346 1.43 . . . . 74.33 107.722 173.148 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.2 m-30 -90.24 43.1 1.13 Allowed 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.822 2.049 . . . . 71.44 108.245 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.406 ' H ' ' HG3' ' A' ' 37' ' ' LYS . 37.0 mtpt -54.25 -42.27 69.74 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 125.932 1.693 . . . . 62.22 109.136 177.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -65.1 -27.9 69.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.78 0.832 . . . . 73.42 111.878 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.9 -5.13 58.22 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.979 1.712 . . . . 71.23 112.301 -176.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.44 95.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 120.818 1.644 . . . . 63.41 109.0 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -80.94 142.9 33.03 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.003 -1.48 . . . . 72.43 107.003 168.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 mmtm -107.41 150.25 26.97 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.509 -1.293 . . . . 64.42 107.509 164.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.37 170.54 16.45 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.836 0.855 . . . . 74.24 108.77 171.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.15 -42.68 99.0 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.586 0.754 . . . . 54.51 110.152 168.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.86 2.63 2.46 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.888 1.275 . . . . 75.52 112.505 173.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.55 46.4 55.29 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 125.915 1.721 . . . . 22.12 111.352 169.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.433 ' HB3' ' H ' ' A' ' 48' ' ' GLY . 1.1 t80 -86.54 -100.21 0.07 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.216 -0.661 . . . . 62.25 109.216 -175.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.433 ' H ' ' HB3' ' A' ' 47' ' ' PHE . . . 138.38 112.42 1.08 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.325 1.917 . . . . 71.11 108.682 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -137.04 159.24 42.49 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.202 1.801 . . . . 73.31 108.447 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.428 HD12 ' CD1' ' A' ' 33' ' ' PHE . 39.5 mt -142.39 142.24 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 106.694 -1.595 . . . . 72.22 106.694 170.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.79 133.46 43.25 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.985 0.914 . . . . 73.13 108.716 165.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.426 ' C ' HD12 ' A' ' 52' ' ' ILE . 1.5 pp -129.9 12.19 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.779 -0.646 . . . . 71.54 110.611 172.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.61 -22.3 16.93 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 119.217 0.917 . . . . 34.22 112.176 170.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -73.91 -25.49 60.03 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.847 1.259 . . . . 51.11 112.456 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.25 -23.05 64.74 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.432 1.014 . . . . 73.22 110.58 167.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 m120 61.57 -6.35 0.12 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.975 1.472 . . . . 72.43 114.975 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.6 mt -45.81 143.86 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 128.337 2.655 . . . . 62.23 111.006 -172.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -102.91 134.78 45.76 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.311 0.96 . . . . 63.51 112.088 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.4 tt -104.3 148.39 9.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 125.842 1.657 . . . . 71.14 107.582 172.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -70.05 112.88 6.74 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.427 -1.694 . . . . 65.41 106.427 165.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 t -107.47 -166.47 1.15 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.153 -1.425 . . . . 71.12 107.153 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.93 159.62 44.44 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.717 -1.586 . . . . 74.42 106.717 167.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -113.88 116.71 29.73 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.01 1.324 . . . . 74.43 110.463 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -57.33 -26.73 61.4 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.814 1.646 . . . . 72.24 113.16 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.31 -22.22 64.69 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.645 1.578 . . . . 54.02 112.422 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.4 m -149.04 10.4 0.79 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.177 0.991 . . . . 64.22 112.451 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.5 mt 54.27 49.42 18.62 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.879 1.323 . . . . 72.52 109.519 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.7 pt -108.44 151.72 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 124.933 1.293 . . . . 64.32 108.618 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.99 124.09 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.048 -1.834 . . . . 52.14 106.048 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -143.09 179.54 6.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.83 1.652 . . . . 62.35 107.767 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.94 168.83 19.14 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.962 0.905 . . . . 73.41 110.652 169.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.56 175.73 13.52 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.711 -1.218 . . . . 75.23 107.711 140.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -105.25 136.77 44.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.708 1.203 . . . . 74.53 108.745 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.9 mt -67.9 157.34 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.748 -1.204 . . . . 71.42 107.748 170.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.442 HD12 ' HG2' ' A' ' 158' ' ' GLU . 37.4 mt -117.96 -43.7 2.75 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.271 0.629 . . . . 74.11 110.839 -175.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.425 ' H ' ' HB ' ' A' ' 156' ' ' THR . 53.1 mtt180 -138.17 165.01 27.72 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.743 -1.223 . . . . 74.42 109.316 169.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.452 HG21 HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -128.58 168.16 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 124.776 1.23 . . . . 53.51 108.894 173.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -135.72 155.59 50.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.733 1.213 . . . . 74.31 109.165 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -139.03 144.64 38.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.551 -1.278 . . . . 74.22 107.551 167.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -141.0 169.03 18.38 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.211 1.405 . . . . 62.32 107.73 169.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -103.94 147.45 27.34 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.248 -1.019 . . . . 61.44 108.248 170.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -145.92 149.34 34.04 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 125.817 1.647 . . . . 72.42 107.352 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -144.68 131.91 20.63 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.309 -1.738 . . . . 75.14 106.309 159.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.77 -169.57 40.8 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.375 -1.09 . . . . 61.34 110.375 -175.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.94 123.74 42.06 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.025 -0.732 . . . . 63.12 109.025 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.6 mt -102.35 149.13 24.65 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.566 -0.901 . . . . 72.45 108.566 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.5 mm -79.47 138.87 19.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 126.192 1.797 . . . . 64.42 107.005 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -122.91 43.66 2.87 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.716 0.806 . . . . 72.12 112.511 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 8.8 mt -46.27 114.78 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 C-N-CA 126.917 2.087 . . . . 55.45 106.753 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.2 m -90.63 169.22 11.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.741 -1.577 . . . . 74.32 106.741 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.8 p -133.96 171.9 13.55 Favored 'General case' 0 C--O 1.238 0.5 0 O-C-N 121.174 -0.954 . . . . 72.31 108.908 157.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -53.73 -38.49 64.38 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.293 -0.88 . . . . 71.24 111.978 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.34 20.11 0.07 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.468 2.307 . . . . 75.11 112.466 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 49.11 27.14 1.64 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 128.091 2.556 . . . . 73.31 113.065 -174.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -65.88 159.86 24.58 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 120.862 -1.149 . . . . 64.32 108.424 163.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 89' ' ' ILE . 1.8 pp20? -170.32 167.06 8.56 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.995 1.718 . . . . 74.14 107.901 166.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.549 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.4 pt -146.75 174.59 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 127.088 2.155 . . . . 74.44 107.914 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -141.72 84.07 1.88 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.835 -0.802 . . . . 74.32 108.835 -171.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.53 HD22 ' CD2' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -142.09 174.41 10.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.983 0.913 . . . . 64.45 112.533 -168.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.77 169.01 8.58 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.065 2.146 . . . . 34.23 111.68 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -83.97 -33.29 24.64 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.306 -0.628 . . . . 64.15 109.306 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -91.69 39.37 1.01 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.769 0.828 . . . . 51.53 110.851 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.53 ' CD2' HD22 ' A' ' 99' ' ' LEU . 4.2 t60 -91.79 123.0 64.54 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 117.166 -1.397 . . . . 74.11 110.106 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -65.78 124.13 12.3 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.182 2.588 . . . . 74.44 110.405 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.22 173.69 8.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 125.735 1.614 . . . . 74.24 108.334 173.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -113.7 149.66 34.41 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 123.037 0.535 . . . . 73.12 110.808 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.11 164.38 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 124.96 1.304 . . . . 72.52 109.689 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 p -79.93 131.83 35.92 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 122.089 0.947 . . . . 51.32 108.462 168.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -109.2 78.13 1.11 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.777 -1.564 . . . . 71.32 106.777 153.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m 61.28 15.13 6.18 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.562 1.545 . . . . 71.35 113.288 166.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.35 -24.36 3.23 Favored Glycine 0 CA--C 1.521 0.416 0 O-C-N 120.808 -1.182 . . . . 75.14 111.752 -173.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -90.1 143.28 26.92 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.533 -1.284 . . . . 55.24 107.533 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.18 126.64 38.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.737 -1.949 . . . . 41.31 105.737 166.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 tp -126.01 159.21 33.32 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.629 -0.878 . . . . 74.12 108.629 173.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -119.81 119.54 33.89 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.145 1.778 . . . . 74.24 109.255 -171.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.55 179.64 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.344 1.057 . . . . 62.23 110.76 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -81.65 139.57 34.9 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.583 1.953 . . . . 63.22 110.69 173.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.21 -41.11 36.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.402 1.481 . . . . 62.11 113.241 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -63.45 -19.85 65.07 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.963 1.256 . . . . 73.31 113.515 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.5 mmt -84.56 -22.83 29.95 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.697 0.799 . . . . 52.22 111.163 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.05 63.66 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 128.398 2.679 . . . . 73.43 111.603 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.428 ' HA ' HG11 ' A' ' 143' ' ' VAL . 0.9 OUTLIER -91.35 -170.68 2.7 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.984 -1.073 . . . . 62.53 111.73 -178.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.9 p -58.96 -1.44 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 127.046 2.139 . . . . 72.35 113.598 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.35 9.21 22.45 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 117.42 -1.767 . . . . 55.21 111.762 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.23 147.64 44.02 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.849 2.325 . . . . 72.25 109.018 172.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -94.81 105.02 16.93 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.236 -1.394 . . . . 75.22 107.236 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.5 tt -78.4 118.16 25.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 124.634 1.173 . . . . 44.12 109.277 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -59.43 140.25 56.34 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.505 -0.747 . . . . 71.54 109.078 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.24 158.02 76.2 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.868 1.267 . . . . 74.13 111.095 174.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.55 161.36 42.39 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.63 2.22 . . . . 53.04 110.277 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.435 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -125.2 -145.6 0.33 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.32 -1.363 . . . . 62.13 107.32 166.254 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.455 ' ND2' ' H ' ' A' ' 133' ' ' ASN . 1.5 p-10 -59.94 -82.04 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 125.44 1.496 . . . . 65.34 109.083 -175.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.455 ' H ' ' ND2' ' A' ' 132' ' ' ASN . 6.4 m120 -102.04 0.47 35.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.855 1.662 . . . . 64.15 110.306 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.9 p -138.12 -172.93 3.38 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.434 1.494 . . . . 62.12 110.857 -150.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 tp -126.02 143.22 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 106.18 -1.785 . . . . 60.51 106.18 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.78 177.56 7.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.648 1.113 . . . . 74.15 108.017 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.3 mt -114.08 145.71 41.24 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.917 1.287 . . . . 73.24 107.965 170.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -142.15 153.98 44.5 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.878 2.071 . . . . 40.42 109.906 170.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.94 142.04 27.83 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 118.427 -0.797 . . . . 73.43 110.017 -164.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.6 t -77.33 -5.57 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 114.544 1.313 . . . . 71.43 114.544 -163.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.488 HG13 ' H ' ' A' ' 142' ' ' LYS . 3.4 pt 29.34 -88.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 127.674 2.39 . . . . 41.25 116.155 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.488 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.8 OUTLIER -86.03 128.56 34.88 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.922 2.089 . . . . 75.55 109.574 -175.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -128.97 99.03 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 125.017 1.327 . . . . 73.35 111.097 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -152.57 -169.43 3.34 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.203 2.601 . . . . 73.14 110.12 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -133.9 179.58 6.15 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.025 1.73 . . . . 74.25 110.105 -172.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.6 163.78 22.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 126.913 2.085 . . . . 53.45 106.478 159.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.0 137.0 37.45 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.903 -1.888 . . . . 75.41 105.903 161.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -147.37 142.94 27.61 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.819 0.736 . . . . 74.42 110.075 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -146.79 24.32 1.2 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 118.839 0.745 . . . . 74.23 112.635 -157.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -109.89 -111.65 3.39 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 110.366 -1.094 . . . . 63.15 110.366 -155.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -134.15 164.82 26.51 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.614 -1.624 . . . . 75.22 106.614 157.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 8' ' ' ALA . 20.6 pt -127.08 160.51 35.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 127.141 2.176 . . . . 73.41 109.111 174.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -142.91 151.55 41.12 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.546 1.138 . . . . 73.41 109.706 -168.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -149.27 -178.78 6.59 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.793 -1.188 . . . . 63.34 107.793 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 77.4 mt -128.26 175.77 8.2 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 123.952 1.834 . . . . 72.12 110.973 -167.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.425 ' HB ' ' H ' ' A' ' 76' ' ' ARG . 24.2 m -128.43 92.09 3.37 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.406 -2.442 . . . . 54.43 104.406 159.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 24.6 t -109.68 80.17 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 101.617 -3.475 . . . . 63.21 101.617 166.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.442 ' HG2' HD12 ' A' ' 75' ' ' LEU . 14.6 pt-20 -76.43 -15.39 59.93 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 122.326 1.06 . . . . 71.53 111.246 -177.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -72.48 -44.49 62.23 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.824 1.65 . . . . 64.21 109.909 -153.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -125.05 5.0 7.93 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.168 0.587 . . . . 65.14 111.89 167.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 52.23 36.67 20.01 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 119.003 0.82 . . . . 72.21 111.933 -174.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.0 p -147.37 142.45 27.1 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 120.422 -1.424 . . . . 74.23 107.613 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.565 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.8 p90 -142.91 170.19 16.16 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.54 1.064 . . . . 73.11 110.288 175.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.1 mm -98.25 137.98 24.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 106.999 -1.482 . . . . 72.15 106.999 160.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -159.71 161.31 34.78 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.299 1.04 . . . . 65.25 108.572 161.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' A' ' 97' ' ' ILE . . . 134.64 -168.17 23.65 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 118.581 0.628 . . . . 72.23 111.757 175.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -102.4 169.52 8.63 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.398 1.599 . . . . 75.12 110.348 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 68.33 -85.13 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 128.05 2.54 . . . . 53.04 113.281 -173.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.471 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -122.68 -23.49 5.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.391 1.077 . . . . 72.13 112.106 169.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.69 177.14 23.95 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 125.643 1.592 . . . . 24.42 111.468 167.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.549 ' CE1' HG23 ' A' ' 97' ' ' ILE . 51.2 m-85 -117.8 140.0 50.3 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 126.353 1.861 . . . . 63.54 108.071 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.46 99.27 10.0 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 129.626 3.171 . . . . 53.12 107.53 170.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.96 179.07 3.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 123.092 0.557 . . . . 71.33 110.298 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.7 t -64.34 148.89 49.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.273 -1.01 . . . . 60.31 108.273 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.565 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -120.78 166.73 13.33 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.026 -1.472 . . . . 60.44 107.026 158.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 92.0 p -149.25 -149.68 0.31 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 119.76 -0.776 . . . . 73.45 111.152 171.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.5 p -149.39 -106.32 0.07 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.786 2.034 . . . . 74.32 107.06 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -88.74 112.05 3.88 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 108.118 -1.993 . . . . 53.42 108.118 165.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . 0.312 0.1 OUTLIER 68.23 -172.03 0.19 Allowed 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.158 1.383 . . . . 64.54 112.06 159.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 53.0 tp -67.64 81.65 0.18 Allowed 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.755 -1.216 . . . . 65.13 109.339 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 50.01 56.31 8.1 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.925 2.49 . . . . 61.32 115.893 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -80.31 -48.76 12.52 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.841 1.423 . . . . 55.13 114.841 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 61.9 m170 31.73 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 128.742 2.817 . . . . 74.53 114.216 -163.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -104.3 90.41 3.55 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.481 0.712 . . . . 71.43 109.949 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.77 -128.22 0.22 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.515 1.126 . . . . 62.42 110.053 169.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 17.0 p80 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 125.155 1.382 . . . . 74.54 109.996 -179.938 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 mtm . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 106.354 -1.721 . . . . 72.430000000000007 106.354 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.33 173.65 11.39 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.234 0.54 . . . . 73.120000000000005 110.749 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.9 m -81.23 -63.05 1.48 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.352 1.061 . . . . 71.329999999999998 108.509 170.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.0 -150.41 1.82 Allowed Glycine 0 C--N 1.341 0.841 0 N-CA-C 109.697 -1.361 . . . . 65.239999999999995 109.697 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 60.96 -174.21 0.13 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.634 1.174 . . . . 72.310000000000002 110.375 -166.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 58.44 84.52 0.1 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.104 1.762 . . . . 65.319999999999993 111.352 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.08 -169.04 39.37 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.462 1.506 . . . . 73.329999999999998 112.863 -176.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.439 ' HB3' HD12 ' A' ' 152' ' ' ILE . . . -177.41 170.84 2.05 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 128.124 2.57 . . . . 60.229999999999997 107.662 165.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mp -110.4 156.82 20.27 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.772 2.029 . . . . 60.420000000000002 110.297 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.14 158.95 27.3 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 121.056 0.455 . . . . 62.229999999999997 110.433 172.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.421 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 26.6 t80 -53.28 -36.95 61.72 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.784 1.634 . . . . 72.409999999999997 113.971 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -111.49 33.75 4.53 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.171 1.788 . . . . 62.229999999999997 111.029 -170.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.33 124.17 70.36 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 107.523 -1.288 . . . . 40.530000000000001 107.523 162.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -61.19 156.81 43.11 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.474 2.116 . . . . 60.43 113.34 164.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.0 pt -126.66 -4.96 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.717 1.607 . . . . 75.430000000000007 113.61 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.471 ' CE2' ' HA ' ' A' ' 169' ' ' GLU . 11.2 m-85 47.6 76.89 0.1 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.653 1.581 . . . . 74.209999999999994 113.143 170.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.68 160.08 0.96 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.815 -0.629 . . . . 63.130000000000003 110.07 169.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.45 0.24 0.32 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.749 1.22 . . . . 73.340000000000003 112.209 167.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -118.16 -16.74 9.71 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.857 2.063 . . . . 51.020000000000003 111.514 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.2 38.26 7.35 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 123.788 0.708 . . . . 25.43 112.483 169.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.16 -16.39 64.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.721 1.378 . . . . 72.540000000000006 114.721 -167.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.268 31.2 mm 35.74 66.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 128.733 2.813 . . . . 62.43 110.489 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.38 151.89 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 127.93 2.492 . . . . 63.420000000000002 108.611 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -65.04 127.01 29.83 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 128.196 2.598 . . . . 61.420000000000002 107.775 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -51.11 -41.44 23.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 123.305 0.642 . . . . 74.349999999999994 111.431 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.421 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -68.49 -41.42 84.78 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-O 118.986 -0.897 . . . . 72.109999999999999 111.154 -175.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.64 -41.01 93.11 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.669 1.234 . . . . 72.209999999999994 110.679 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -57.34 -57.12 14.03 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.96 0.904 . . . . 71.450000000000003 108.89 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.452 HG13 HG21 ' A' ' 77' ' ' VAL . 53.2 t -56.14 -50.97 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 109.129 -0.693 . . . . 71.230000000000004 109.129 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.3 -32.47 73.89 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 119.463 1.028 . . . . 72.230000000000004 112.032 -167.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.483 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 4.5 tttt -48.22 -47.05 35.89 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.418 1.008 . . . . 65.420000000000002 108.828 173.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.483 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 24.7 m-85 -68.69 -43.67 75.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.482 -0.933 . . . . 75.549999999999997 108.482 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.428 ' CD1' HD12 ' A' ' 50' ' ' ILE . 5.6 m-85 -64.0 -21.98 66.73 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.157 -0.965 . . . . 71.319999999999993 112.102 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -93.93 -20.05 20.37 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 125.33 1.452 . . . . 72.140000000000001 112.483 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.417 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -94.42 -52.55 4.28 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 120.346 1.43 . . . . 74.329999999999998 107.722 173.148 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.2 m-30 -90.24 43.1 1.13 Allowed 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.822 2.049 . . . . 71.439999999999998 108.245 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.406 ' H ' ' HG3' ' A' ' 37' ' ' LYS . 37.0 mtpt -54.25 -42.27 69.74 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 125.932 1.693 . . . . 62.219999999999999 109.136 177.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -65.1 -27.9 69.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.78 0.832 . . . . 73.420000000000002 111.878 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.9 -5.13 58.22 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.979 1.712 . . . . 71.230000000000004 112.301 -176.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.44 95.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 120.818 1.644 . . . . 63.409999999999997 109.0 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -80.94 142.9 33.03 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.003 -1.48 . . . . 72.430000000000007 107.003 168.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 mmtm -107.41 150.25 26.97 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.509 -1.293 . . . . 64.420000000000002 107.509 164.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.37 170.54 16.45 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.836 0.855 . . . . 74.239999999999995 108.77 171.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.15 -42.68 99.0 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.586 0.754 . . . . 54.509999999999998 110.152 168.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.86 2.63 2.46 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.888 1.275 . . . . 75.519999999999996 112.505 173.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.55 46.4 55.29 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 125.915 1.721 . . . . 22.120000000000001 111.352 169.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.433 ' HB3' ' H ' ' A' ' 48' ' ' GLY . 1.1 t80 -86.54 -100.21 0.07 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.216 -0.661 . . . . 62.25 109.216 -175.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.433 ' H ' ' HB3' ' A' ' 47' ' ' PHE . . . 138.38 112.42 1.08 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.325 1.917 . . . . 71.109999999999999 108.682 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -137.04 159.24 42.49 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.202 1.801 . . . . 73.310000000000002 108.447 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.428 HD12 ' CD1' ' A' ' 33' ' ' PHE . 39.5 mt -142.39 142.24 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 106.694 -1.595 . . . . 72.219999999999999 106.694 170.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.79 133.46 43.25 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.985 0.914 . . . . 73.129999999999995 108.716 165.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.426 ' C ' HD12 ' A' ' 52' ' ' ILE . 1.5 pp -129.9 12.19 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.779 -0.646 . . . . 71.540000000000006 110.611 172.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.61 -22.3 16.93 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 119.217 0.917 . . . . 34.219999999999999 112.176 170.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -73.91 -25.49 60.03 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.847 1.259 . . . . 51.109999999999999 112.456 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.25 -23.05 64.74 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.432 1.014 . . . . 73.219999999999999 110.58 167.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 m120 61.57 -6.35 0.12 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.975 1.472 . . . . 72.430000000000007 114.975 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.6 mt -45.81 143.86 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 128.337 2.655 . . . . 62.229999999999997 111.006 -172.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -102.91 134.78 45.76 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.311 0.96 . . . . 63.509999999999998 112.088 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.4 tt -104.3 148.39 9.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 125.842 1.657 . . . . 71.140000000000001 107.582 172.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -70.05 112.88 6.74 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.427 -1.694 . . . . 65.409999999999997 106.427 165.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 t -107.47 -166.47 1.15 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.153 -1.425 . . . . 71.120000000000005 107.153 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.93 159.62 44.44 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.717 -1.586 . . . . 74.420000000000002 106.717 167.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -113.88 116.71 29.73 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.01 1.324 . . . . 74.430000000000007 110.463 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 1.7 ttpm? -57.33 -26.73 61.4 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.814 1.646 . . . . 72.239999999999995 113.16 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.31 -22.22 64.69 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.645 1.578 . . . . 54.020000000000003 112.422 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.4 m -149.04 10.4 0.79 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.177 0.991 . . . . 64.219999999999999 112.451 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.5 mt 54.27 49.42 18.62 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.879 1.323 . . . . 72.519999999999996 109.519 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.7 pt -108.44 151.72 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 124.933 1.293 . . . . 64.319999999999993 108.618 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.99 124.09 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.048 -1.834 . . . . 52.140000000000001 106.048 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -143.09 179.54 6.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.83 1.652 . . . . 62.350000000000001 107.767 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.94 168.83 19.14 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.962 0.905 . . . . 73.409999999999997 110.652 169.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.56 175.73 13.52 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.711 -1.218 . . . . 75.230000000000004 107.711 140.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -105.25 136.77 44.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.708 1.203 . . . . 74.530000000000001 108.745 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.9 mt -67.9 157.34 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.748 -1.204 . . . . 71.420000000000002 107.748 170.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.442 HD12 ' HG2' ' A' ' 158' ' ' GLU . 37.4 mt -117.96 -43.7 2.75 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.271 0.629 . . . . 74.109999999999999 110.839 -175.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.425 ' H ' ' HB ' ' A' ' 156' ' ' THR . 53.1 mtt180 -138.17 165.01 27.72 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.743 -1.223 . . . . 74.420000000000002 109.316 169.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.452 HG21 HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -128.58 168.16 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 124.776 1.23 . . . . 53.509999999999998 108.894 173.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -135.72 155.59 50.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.733 1.213 . . . . 74.310000000000002 109.165 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -139.03 144.64 38.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.551 -1.278 . . . . 74.219999999999999 107.551 167.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -141.0 169.03 18.38 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.211 1.405 . . . . 62.32 107.73 169.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -103.94 147.45 27.34 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.248 -1.019 . . . . 61.439999999999998 108.248 170.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -145.92 149.34 34.04 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 125.817 1.647 . . . . 72.420000000000002 107.352 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -144.68 131.91 20.63 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 106.309 -1.738 . . . . 75.140000000000001 106.309 159.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.77 -169.57 40.8 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.375 -1.09 . . . . 61.340000000000003 110.375 -175.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.94 123.74 42.06 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.025 -0.732 . . . . 63.119999999999997 109.025 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.6 mt -102.35 149.13 24.65 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.566 -0.901 . . . . 72.450000000000003 108.566 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.5 mm -79.47 138.87 19.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 126.192 1.797 . . . . 64.420000000000002 107.005 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -122.91 43.66 2.87 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.716 0.806 . . . . 72.120000000000005 112.511 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 8.8 mt -46.27 114.78 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 C-N-CA 126.917 2.087 . . . . 55.450000000000003 106.753 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.2 m -90.63 169.22 11.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.741 -1.577 . . . . 74.319999999999993 106.741 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.8 p -133.96 171.9 13.55 Favored 'General case' 0 C--O 1.238 0.5 0 O-C-N 121.174 -0.954 . . . . 72.310000000000002 108.908 157.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -53.73 -38.49 64.38 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.293 -0.88 . . . . 71.239999999999995 111.978 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.427 HD22 ' CG ' ' A' ' 138' ' ' ASP . 41.0 m-80 -72.34 20.11 0.07 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.468 2.307 . . . . 75.109999999999999 112.466 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 49.11 27.14 1.64 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 128.091 2.556 . . . . 73.310000000000002 113.065 -174.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -65.88 159.86 24.58 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 120.862 -1.149 . . . . 64.319999999999993 108.424 163.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 89' ' ' ILE . 1.8 pp20? -170.32 167.06 8.56 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.995 1.718 . . . . 74.140000000000001 107.901 166.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.549 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.4 pt -146.75 174.59 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 127.088 2.155 . . . . 74.439999999999998 107.914 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -141.72 84.07 1.88 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.835 -0.802 . . . . 74.319999999999993 108.835 -171.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.53 HD22 ' CD2' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -142.09 174.41 10.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.983 0.913 . . . . 64.450000000000003 112.533 -168.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.77 169.01 8.58 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.065 2.146 . . . . 34.229999999999997 111.68 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -83.97 -33.29 24.64 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.306 -0.628 . . . . 64.150000000000006 109.306 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -91.69 39.37 1.01 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.769 0.828 . . . . 51.530000000000001 110.851 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.53 ' CD2' HD22 ' A' ' 99' ' ' LEU . 4.2 t60 -91.79 123.0 64.54 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 117.166 -1.397 . . . . 74.109999999999999 110.106 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -65.78 124.13 12.3 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.182 2.588 . . . . 74.439999999999998 110.405 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.22 173.69 8.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 125.735 1.614 . . . . 74.239999999999995 108.334 173.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -113.7 149.66 34.41 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 123.037 0.535 . . . . 73.120000000000005 110.808 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.11 164.38 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 124.96 1.304 . . . . 72.519999999999996 109.689 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 p -79.93 131.83 35.92 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 122.089 0.947 . . . . 51.32 108.462 168.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -109.2 78.13 1.11 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.777 -1.564 . . . . 71.319999999999993 106.777 153.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m 61.28 15.13 6.18 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.562 1.545 . . . . 71.349999999999994 113.288 166.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.35 -24.36 3.23 Favored Glycine 0 CA--C 1.521 0.416 0 O-C-N 120.808 -1.182 . . . . 75.140000000000001 111.752 -173.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -90.1 143.28 26.92 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.533 -1.284 . . . . 55.240000000000002 107.533 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.18 126.64 38.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.737 -1.949 . . . . 41.310000000000002 105.737 166.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 tp -126.01 159.21 33.32 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.629 -0.878 . . . . 74.120000000000005 108.629 173.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -119.81 119.54 33.89 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.145 1.778 . . . . 74.239999999999995 109.255 -171.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.55 179.64 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.344 1.057 . . . . 62.229999999999997 110.76 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -81.65 139.57 34.9 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.583 1.953 . . . . 63.219999999999999 110.69 173.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.21 -41.11 36.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.402 1.481 . . . . 62.109999999999999 113.241 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -63.45 -19.85 65.07 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.963 1.256 . . . . 73.310000000000002 113.515 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.5 mmt -84.56 -22.83 29.95 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.697 0.799 . . . . 52.219999999999999 111.163 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.05 63.66 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 128.398 2.679 . . . . 73.430000000000007 111.603 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.428 ' HA ' HG11 ' A' ' 143' ' ' VAL . 0.9 OUTLIER -91.35 -170.68 2.7 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.984 -1.073 . . . . 62.530000000000001 111.73 -178.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.9 p -58.96 -1.44 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 127.046 2.139 . . . . 72.349999999999994 113.598 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.35 9.21 22.45 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 117.42 -1.767 . . . . 55.210000000000001 111.762 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.23 147.64 44.02 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.849 2.325 . . . . 72.25 109.018 172.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -94.81 105.02 16.93 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.236 -1.394 . . . . 75.219999999999999 107.236 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.5 tt -78.4 118.16 25.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 124.634 1.173 . . . . 44.119999999999997 109.277 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -59.43 140.25 56.34 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.505 -0.747 . . . . 71.540000000000006 109.078 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.24 158.02 76.2 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.868 1.267 . . . . 74.129999999999995 111.095 174.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.55 161.36 42.39 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.63 2.22 . . . . 53.039999999999999 110.277 171.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.435 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -125.2 -145.6 0.33 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.32 -1.363 . . . . 62.130000000000003 107.32 166.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.455 ' ND2' ' H ' ' A' ' 133' ' ' ASN . 1.5 p-10 -59.94 -82.04 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 125.44 1.496 . . . . 65.340000000000003 109.083 -175.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.455 ' H ' ' ND2' ' A' ' 132' ' ' ASN . 6.4 m120 -102.04 0.47 35.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.855 1.662 . . . . 64.150000000000006 110.306 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.9 p -138.12 -172.93 3.38 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.434 1.494 . . . . 62.119999999999997 110.857 -150.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 tp -126.02 143.22 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 106.18 -1.785 . . . . 60.509999999999998 106.18 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.78 177.56 7.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.648 1.113 . . . . 74.150000000000006 108.017 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.3 mt -114.08 145.71 41.24 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.917 1.287 . . . . 73.239999999999995 107.965 170.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.427 ' CG ' HD22 ' A' ' 93' ' ' ASN . 32.4 t0 -142.15 153.98 44.5 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.878 2.071 . . . . 40.420000000000002 109.906 170.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.94 142.04 27.83 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 118.427 -0.797 . . . . 73.430000000000007 110.017 -164.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.6 t -77.33 -5.57 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 114.544 1.313 . . . . 71.430000000000007 114.544 -163.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.488 HG13 ' H ' ' A' ' 142' ' ' LYS . 3.4 pt 29.34 -88.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 127.674 2.39 . . . . 41.25 116.155 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.488 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.8 OUTLIER -86.03 128.56 34.88 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.922 2.089 . . . . 75.549999999999997 109.574 -175.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -128.97 99.03 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 125.017 1.327 . . . . 73.349999999999994 111.097 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -152.57 -169.43 3.34 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.203 2.601 . . . . 73.140000000000001 110.12 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -133.9 179.58 6.15 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.025 1.73 . . . . 74.25 110.105 -172.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.6 163.78 22.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 126.913 2.085 . . . . 53.450000000000003 106.478 159.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.0 137.0 37.45 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.903 -1.888 . . . . 75.409999999999997 105.903 161.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -147.37 142.94 27.61 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.819 0.736 . . . . 74.420000000000002 110.075 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -146.79 24.32 1.2 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 118.839 0.745 . . . . 74.230000000000004 112.635 -157.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -109.89 -111.65 3.39 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 110.366 -1.094 . . . . 63.149999999999999 110.366 -155.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -134.15 164.82 26.51 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.614 -1.624 . . . . 75.219999999999999 106.614 157.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 8' ' ' ALA . 20.6 pt -127.08 160.51 35.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 127.141 2.176 . . . . 73.409999999999997 109.111 174.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -142.91 151.55 41.12 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.546 1.138 . . . . 73.409999999999997 109.706 -168.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -149.27 -178.78 6.59 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.793 -1.188 . . . . 63.340000000000003 107.793 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 77.4 mt -128.26 175.77 8.2 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 123.952 1.834 . . . . 72.120000000000005 110.973 -167.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.425 ' HB ' ' H ' ' A' ' 76' ' ' ARG . 24.2 m -128.43 92.09 3.37 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.406 -2.442 . . . . 54.43 104.406 159.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 24.6 t -109.68 80.17 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 101.617 -3.475 . . . . 63.210000000000001 101.617 166.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.442 ' HG2' HD12 ' A' ' 75' ' ' LEU . 14.6 pt-20 -76.43 -15.39 59.93 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 122.326 1.06 . . . . 71.530000000000001 111.246 -177.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -72.48 -44.49 62.23 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.824 1.65 . . . . 64.209999999999994 109.909 -153.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 4.3 t30 -125.05 5.0 7.93 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.168 0.587 . . . . 65.140000000000001 111.89 167.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.415 ' CD2' ' HA ' ' A' ' 176' ' ' SER . 34.8 m170 52.23 36.67 20.01 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 119.003 0.82 . . . . 72.209999999999994 111.933 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.0 p -147.37 142.45 27.1 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 120.422 -1.424 . . . . 74.230000000000004 107.613 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.565 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.8 p90 -142.91 170.19 16.16 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.54 1.064 . . . . 73.109999999999999 110.288 175.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.1 mm -98.25 137.98 24.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 106.999 -1.482 . . . . 72.150000000000006 106.999 160.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -159.71 161.31 34.78 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.299 1.04 . . . . 65.25 108.572 161.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' A' ' 97' ' ' ILE . . . 134.64 -168.17 23.65 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 118.581 0.628 . . . . 72.230000000000004 111.757 175.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -102.4 169.52 8.63 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.398 1.599 . . . . 75.120000000000005 110.348 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 68.33 -85.13 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 128.05 2.54 . . . . 53.039999999999999 113.281 -173.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.471 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -122.68 -23.49 5.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.391 1.077 . . . . 72.129999999999995 112.106 169.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.69 177.14 23.95 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 125.643 1.592 . . . . 24.420000000000002 111.468 167.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.549 ' CE1' HG23 ' A' ' 97' ' ' ILE . 51.2 m-85 -117.8 140.0 50.3 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 126.353 1.861 . . . . 63.539999999999999 108.071 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.46 99.27 10.0 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 129.626 3.171 . . . . 53.119999999999997 107.53 170.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.96 179.07 3.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 123.092 0.557 . . . . 71.329999999999998 110.298 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.7 t -64.34 148.89 49.36 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.273 -1.01 . . . . 60.310000000000002 108.273 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.565 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -120.78 166.73 13.33 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.026 -1.472 . . . . 60.439999999999998 107.026 158.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.415 ' HA ' ' CD2' ' A' ' 161' ' ' HIS . 92.0 p -149.25 -149.68 0.31 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 119.76 -0.776 . . . . 73.450000000000003 111.152 171.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.5 p -149.39 -106.32 0.07 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.786 2.034 . . . . 74.319999999999993 107.06 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -88.74 112.05 3.88 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 108.118 -1.993 . . . . 53.420000000000002 108.118 165.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . 0.312 0.1 OUTLIER 68.23 -172.03 0.19 Allowed 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.158 1.383 . . . . 64.540000000000006 112.06 159.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 53.0 tp -67.64 81.65 0.18 Allowed 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.755 -1.216 . . . . 65.129999999999995 109.339 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 50.01 56.31 8.1 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.925 2.49 . . . . 61.32 115.893 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -80.31 -48.76 12.52 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.841 1.423 . . . . 55.130000000000003 114.841 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 61.9 m170 31.73 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 128.742 2.817 . . . . 74.530000000000001 114.216 -163.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -104.3 90.41 3.55 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.481 0.712 . . . . 71.430000000000007 109.949 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.77 -128.22 0.22 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.515 1.126 . . . . 62.420000000000002 110.053 169.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 17.0 p80 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 125.155 1.382 . . . . 74.540000000000006 109.996 -179.938 . . . . . . . . 0 0 . 1 stop_ save_